Prostacyclin biosynthesis in activated, stimulated and normal mouse peritoneal cell populations

Abstract

Nonspecific resistance to infectious and neoplastic disease can be enhanced by administration of “immunomodulators”. The levels of enhancement can be monitored by following in vitro function of cells of the lympho-reticuloendothelial system. To gain a better understanding of the physiological and biochemical nature of this enhancement, the metabolism of prostaglandin endoperoxide PGH 2 was followed in mouse peritoneal cells (PCs). Homogenates of PCs from normal, unstimulated mice yielded primarily prostacyclin (PGI 2) when incubated with PGH 2. Homogenates of PCs from mice injected with the immunomodulators C . parvum , levamisole HCl, pyran copolymer, or thioglycollate yielded less PGI 2. Reductions ranged from 73% for C . parvum to 32% for levamisole. A statistically significant inverse correlation existed between the level of macrophage “activation” and ability of cellular homogenates to produce prostacyclin. The results suggest that prostacyclin may be involved in modulation of nonspecific resistance.